Biotech Values

[swampboots]

DEW - RE:
<U.S. Medicare decides to reimburse for Visudyne treatment in occult and minimally-classic AMD when lesions are small and disease is rapidly progressing.>

I have many mixed feelings about that lousy statistical long shot being petted to con patience into wasting short vision cycle on that multi tasking nusiance for the desperate.
Best to hand patients picket signs so they can at least get OXGN to get special exempt status for the anti leak blood vessel lottery swab.